Literature DB >> 3074669

Hereditary diabetes in the KK mouse: an overview.

A S Reddi1, R A Camerini-Davalos.   

Abstract

Table III compares metabolic and morphologic characteristics of different species of control and KK mice. The C57BL/6J demonstrates no significant metabolic, clinical or histologic abnormalities. Our two highly inbred Swiss albino groups I and II also do not show significant glomerular lesions, although we found striking intolerance to glucose, hyperinsulinism, and obesity among them. Thus a genetic predisposition may be necessary in addition to various environmental factors to produce microangiopathy in KK mice. The yellow AY mouse is included in this table, since it is strikingly hyperinsulinemic and obese without concomitant vasculopathy such as the other mentioned control strains have. In conclusion, the KK mice develop chemical diabetes preceded by a stage of prediabetes and also demonstrate renal, retinal and neurologic complications similar to those seen in human diabetes. Of particular interest is the development of mild to moderate glomerulosclerosis in the prediabetic stage; with progression to severe glomerulosclerosis and attendant proteinuria later in life. With proper back-crossing, both hyperglycemia and glomerulosclerosis can be transmitted to normal control mice, suggesting that a specific genetic background is necessary for the development of diabetes and diabetic-like microangiopathy. We therefore suggest that the KK mouse serves as an ideal genetic animal for the study of non-insulin-dependent diabetes mellitus and its complications for rational prevention and therapy.

Entities:  

Mesh:

Year:  1988        PMID: 3074669     DOI: 10.1007/978-1-4684-5616-5_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  11 in total

1.  Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice.

Authors:  Yanqiao Zhang; Florence Ying Lee; Gabriel Barrera; Hans Lee; Charisse Vales; Frank J Gonzalez; Timothy M Willson; Peter A Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-12       Impact factor: 11.205

2.  Age-dependent slowing of enteric axonal transport in insulin-resistant mice.

Authors:  Kathy J LePard; Joseph Cellini
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

3.  An extract of Artemisia dracunculus L. enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-A(y) mice.

Authors:  Zhong Q Wang; David Ribnicky; Xian H Zhang; Aamir Zuberi; Ilya Raskin; Yongmei Yu; William T Cefalu
Journal:  J Nutr Biochem       Date:  2010-05-05       Impact factor: 6.048

Review 4.  Metabolic functions of glucocorticoid receptor in skeletal muscle.

Authors:  Taiyi Kuo; Charles A Harris; Jen-Chywan Wang
Journal:  Mol Cell Endocrinol       Date:  2013-03-21       Impact factor: 4.102

5.  Glycosphingolipid modification: structural diversity, functional and mechanistic integration of diabetes.

Authors:  Tadashi Yamashita
Journal:  Diabetes Metab J       Date:  2011-08-31       Impact factor: 5.376

6.  Role of nerve growth factor in cutaneous wound healing: accelerating effects in normal and healing-impaired diabetic mice.

Authors:  H Matsuda; H Koyama; H Sato; J Sawada; A Itakura; A Tanaka; M Matsumoto; K Konno; H Ushio; K Matsuda
Journal:  J Exp Med       Date:  1998-02-02       Impact factor: 14.307

7.  A tripeptide Diapin effectively lowers blood glucose levels in male type 2 diabetes mice by increasing blood levels of insulin and GLP-1.

Authors:  Jifeng Zhang; Changyong Xue; Tianqing Zhu; Anuradha Vivekanandan; Subramaniam Pennathur; Zhongmin Alex Ma; Y Eugene Chen
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

Review 8.  Animal Models of Diabetes-Associated Renal Injury.

Authors:  Zahra Samadi Noshahr; Hossein Salmani; Abolfazl Khajavi Rad; Amirhossein Sahebkar
Journal:  J Diabetes Res       Date:  2020-05-20       Impact factor: 4.011

Review 9.  Rodent animal models: from mild to advanced stages of diabetic nephropathy.

Authors:  Manpreet Kaur; Onkar Bedi; Shilpi Sachdeva; B V K Krishna Reddy; Puneet Kumar
Journal:  Inflammopharmacology       Date:  2014-08-23       Impact factor: 4.473

Review 10.  Current status and patent prospective of animal models in diabetic research.

Authors:  Radhey S Dhuria; Gurpreet Singh; Anudeep Kaur; Ramandeep Kaur; Tanurajvir Kaur
Journal:  Adv Biomed Res       Date:  2015-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.